Advancing novel oral polio vaccines: planning for long–term protection against polio resurgence

This fact sheet provides an overview of the novel oral polio vaccine (nOPV) program—a consortium of PATH and partners that are working to advance novel vaccine candidates that will enable complete eradication and minimize the risk of polio resurgence.

Corporate author(s): PATH

Publication date: January 2024

Advancing novel oral polio vaccines: planning for long–term protection against polio resurgence.

1 MB PDF

Hard copies are not available.
View Resource